Recently, a storm has brewed in the pharmaceutical and healthcare industry. An area that leads and aggregates international pharmaceutical innovation resources - BioPark is on the verge of rising in the southern part of the capital. Multinational pharmaceutical companies such as Eli Lilly, Pfizer, Bayer, and Medtronic have been setting up new R & D institutions and flocking to this place. What kind of "park" has such great allure? Let's explore it together in this article.
This year's Municipal Government Work Report clearly states that "building an International Pharmaceutical Innovation Park" is one of the key tasks for developing and strengthening high - end, sophisticated, and cutting - edge industries. The International Pharmaceutical Innovation Park (BioPark) is located in Jiugong Town, Daxing District, on the western side of Yizhuang New Town. It is adjacent to the South Central Axis on the west, and the South 5th Ring Road, Jingtai Expressway, and Subway Line 8 run through the area.
It is about 30 minutes' drive from Daxing Biomedical Industry Base, approximately 10 minutes' drive from Daxing Economic and Technological Development Zone, and only 30 minutes' drive from Daxing International Airport.
The total planned land area is around 6.5 square kilometers, making it the last industrial cluster area along the Beijing 5th Ring Road. It is reported that the "park" integrates R & D, manufacturing, living, and leisure. Currently, six major centers of the National Medical Products Administration and six R & D centers of foreign - funded pharmaceutical companies have been established here. The existing Yinluchi Park, Wufutang Park, and Citizen's Park will be renovated and upgraded, and a Central Green Space Park will be constructed in the future.
Among the parks and green spaces, there are four functional areas, each with its own unique features. They are the Headquarters Agglomeration Area, the R & D and Transformation Area, the Medical - Industrial Integration Area, and the Pharmaceutical Intelligent Manufacturing Area, which can meet the spatial requirements of enterprises at every stage, from R & D, pilot - scale testing to large - scale production.
The Headquarters Agglomeration Area, as the currently completed area of the International Pharmaceutical Innovation Park (BioPark), is the starting point for promoting the overall regional development and the core area for the implementation of current key projects. Surrounding the office locations of the six major centers of the National Medical Products Administration, this area has gathered abundant innovation resources, attracting multinational pharmaceutical companies like Eli Lilly, Pfizer, Bayer, and Medtronic to set up R & D institutions here. In the future, it aims to build a globally - influential international enterprise headquarters cluster.
The Medical - Industrial Integration Area plans to build a research - type hospital, a scientific and technological achievement transformation platform, and an industry - education integration base. It will cooperate with universities such as Peking University and Tsinghua University in R & D and industry - education integration. The R & D and Transformation Area, aiming at the R & D and pilot - scale production needs of international enterprise products, will build high - standard industrial - level professional R & D and industrial spaces, accelerating the implementation of innovative achievements. The Pharmaceutical Intelligent Manufacturing Area plans to build modern intelligent manufacturing factories, which will undertake functions such as biopharmaceutical production, warehousing, and logistics.
The construction of the International Pharmaceutical Innovation Park will form a pharmaceutical innovation center that can drive the development of southern Beijing and connect global innovation resources. It is of great significance for deeply participating in the global pharmaceutical and healthcare innovation cooperation network and improving the pharmaceutical and healthcare ecosystem.
As an important base for the International Pharmaceutical Innovation Park, Daxing District will seize the opportunity, ride the wave, actively integrate resources, and give full play to its own advantages. It will collaborate with Yizhuang New Town in aspects such as rail transit, housing security, policy support, education and medical care, environmental facilities, and park - supporting services to achieve coordinated development, and actively create new momentum for the pharmaceutical and healthcare industry in southern Beijing and even in Beijing.
As an important carrier for the development of the life and health industry in Beijing, Daxing Biomedical Industry Base is the largest professional pharmaceutical and healthcare park in the country. In recent years, the pharmaceutical and healthcare industry in Daxing District has been booming. The number of drug clinical trials and approved market launches ranks among the top in the city. Twelve national - level inspection and R & D institutions have settled here, and more than 120 enterprise - service platforms such as Beijing Biocytogen Co., Ltd. have been established, forming a full - chain service system. The planned relocation of the research - type hospital affiliated with Capital Medical University will further enrich the innovation resources. The Daxing section of the Airport Economic Zone and the Beijing - Japan Innovation Cooperation Demonstration Zone also regard life and health as key development industries. With the superposition of multiple policies, they have broad development space, can share resources and benefit from policies with the Innovation Park, contribute to its development, accelerate the transformation of pharmaceutical and healthcare innovation resources into industrial advantages, and promote the enhancement of the global competitiveness of the pharmaceutical and healthcare industry.
